Improving HPV vaccination rates through enhanced physician communication
PCOM2 - The Physician Communication Intervention, Version 2.0" for "Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake"
This study is testing a new online way for doctors to talk to teens about getting the HPV vaccine to see if it helps more of them get vaccinated compared to the usual method.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 9 Years to 17 Years |
| Sex | All |
| Sponsor | University of Colorado, Denver Academic / other |
| Locations | 2 sites (Aurora, Colorado and 1 other locations) |
| Trial ID | NCT05336240 on ClinicalTrials.gov |
What this trial studies
This study aims to develop and evaluate a virtual version of the Physician Communication Intervention (PCOM) to improve HPV vaccination rates among adolescents. By comparing the efficacy of the new PCOM-Virtual intervention to the original PCOM-Standard, the researchers will assess how well each approach increases vaccination rates. The study will utilize mixed methods to understand the contextual factors that influence the effectiveness of these interventions. Ultimately, the goal is to create a user-friendly intervention that can be widely implemented in primary care settings to enhance adolescent preventive health services.
Who should consider this trial
Good fit: Ideal candidates for this study are parents of adolescents aged 9-17 years who are receiving care at participating clinics.
Not a fit: Patients who do not have adolescents in the specified age range or are not receiving care at enrolled clinics will not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly increase HPV vaccination rates among adolescents, reducing their risk of HPV-associated cancers and diseases.
How similar studies have performed: Previous studies using similar communication interventions have shown success in increasing HPV vaccination rates, indicating that this approach has potential.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Parents: Have an adolescent between the ages of 9-17 years old and receiving adolescent care at an enrolled clinic * Providers: All providers at participating study practices will be eligible to participate. Exclusion Criteria: * Parents: Does not have an adolescent between the ages of 9-17 years old and is not receiving adolescent care at an enrolled clinic * Providers: Providers who are not at participating study practices
Where this trial is running
Aurora, Colorado and 1 other locations
- University of Colorado Anschutz Medical Campus — Aurora, Colorado, United States (Recruiting)
- University of Kansas Medical Center — Wichita, Kansas, United States (Recruiting)
Study contacts
- Principal investigator: Sean O'Leary, MD, MPH — University of Colorado, Denver
- Study coordinator: Christine Spina, MSPH
- Email: CHRISTINE.BABBEL@CUANSCHUTZ.EDU
- Phone: 303.724.0906
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.